Compare Stocks: AMED, FMS, BTSG, and TEM

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMED Amedisys	$101.01 +0.0%	$99.72	$92.44 ▼ $101.02	$3.32B	0.89	509,062 shs	1.06 million shs
BTSG BrightSpring Health Services	$63.02 +0.4%	$66.51	$19.51 ▼ $73.75	$12.42B	1.88	4.72 million shs	3.22 million shs
FMS Fresenius Medical Care AG & Co. KGaA	$23.91 -0.4%	$23.49	$20.02 ▼ $27.64	$12.90B	0.77	662,012 shs	1.43 million shs
TEM Tempus AI	$46.70 -0.7%	$51.40	$40.77 ▼ $104.32	$8.45B	3.58	5.17 million shs	3.50 million shs

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMED Amedisys	0.00%	0.00%	0.00%	0.00%	+2.55%
BTSG BrightSpring Health Services	+3.67%	-13.48%	-9.18%	+18.87%	+223.82%
FMS Fresenius Medical Care AG & Co. KGaA	-5.14%	-2.85%	+2.14%	+14.28%	-3.48%
TEM Tempus AI	+2.17%	+9.67%	-21.93%	-12.06%	-18.20%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMED Amedisys	$101.01 +0.0%	$99.72	$92.44 ▼ $101.02	$3.32B	0.89	509,062 shs	1.06 million shs
BTSG BrightSpring Health Services	$63.02 +0.4%	$66.51	$19.51 ▼ $73.75	$12.42B	1.88	4.72 million shs	3.22 million shs
FMS Fresenius Medical Care AG & Co. KGaA	$23.91 -0.4%	$23.49	$20.02 ▼ $27.64	$12.90B	0.77	662,012 shs	1.43 million shs
TEM Tempus AI	$46.70 -0.7%	$51.40	$40.77 ▼ $104.32	$8.45B	3.58	5.17 million shs	3.50 million shs

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMED Amedisys	0.00%	0.00%	0.00%	0.00%	+2.55%
BTSG BrightSpring Health Services	+3.67%	-13.48%	-9.18%	+18.87%	+223.82%
FMS Fresenius Medical Care AG & Co. KGaA	-5.14%	-2.85%	+2.14%	+14.28%	-3.48%
TEM Tempus AI	+2.17%	+9.67%	-21.93%	-12.06%	-18.20%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMED Amedisys	0.00	N/A	N/A	N/A
BTSG BrightSpring Health Services	3.00	Buy	$70.71	12.20% Upside
FMS Fresenius Medical Care AG & Co. KGaA	1.55	Reduce	$22.45	-6.09% Downside
TEM Tempus AI	2.41	Hold	$64.92	39.02% Upside

Current Analyst Ratings Breakdown

Latest AMED, FMS, BTSG, and TEM Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/5/2026	FMS Fresenius Medical Care AG & Co. KGaA	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$25.00
8/4/2026	TEM Tempus AI	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral	$58.00 ➝ $56.00
8/3/2026	BTSG BrightSpring Health Services	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight
8/3/2026	BTSG BrightSpring Health Services	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$70.00
8/3/2026	BTSG BrightSpring Health Services	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$90.00
8/3/2026	TEM Tempus AI	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$80.00 ➝ $70.00
8/3/2026	TEM Tempus AI	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$64.00 ➝ $56.00
8/3/2026	TEM Tempus AI	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Hold	$60.00 ➝ $50.00
7/31/2026	BTSG BrightSpring Health Services	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy (B-)
7/31/2026	TEM Tempus AI	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$75.00
7/28/2026	FMS Fresenius Medical Care AG & Co. KGaA	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Neutral ➝ Underperform	$19.90

(Data available from 8/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMED Amedisys	$2.40B	1.38	$6.24 per share	16.20	$38.77 per share	2.61
BTSG BrightSpring Health Services	$12.91B	0.97	$2.29 per share	27.51	$10.35 per share	6.09
FMS Fresenius Medical Care AG & Co. KGaA	$19.36B	0.66	$5.27 per share	4.54	$28.93 per share	0.83
TEM Tempus AI	$1.27B	6.59	N/A	N/A	$2.48 per share	18.83

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMED Amedisys	$43.23M	$2.57	39.30	20.87	1.34	3.56%	12.91%	7.29%	N/A
BTSG BrightSpring Health Services	$190.67M	$1.66	37.96	28.52	0.74	2.55%	16.73%	5.24%	10/19/2026 (Estimated)
FMS Fresenius Medical Care AG & Co. KGaA	$1.11B	$1.90	12.58	9.92	4.49	4.83%	9.19%	4.17%	N/A
TEM Tempus AI	-$245.03M	-$1.44	N/A	N/A	N/A	-17.77%	-50.28%	-10.33%	N/A

Latest AMED, FMS, BTSG, and TEM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/3/2026	Q2 2026	FMS Fresenius Medical Care AG & Co. KGaA	$0.6160	$0.66	+$0.0440	$0.46	$5.48 billion	$5.55 billion
7/31/2026	Q2 2026	BTSG BrightSpring Health Services	$0.3963	$0.45	+$0.0537	$0.38	$3.66 billion	$3.87 billion
7/30/2026	Q2 2026	TEM Tempus AI	-$0.1428	-$0.04	+$0.1028	$0.03	$379.69 million	$382.49 million
5/5/2026	Q1 2026	FMS Fresenius Medical Care AG & Co. KGaA	$0.59	$0.53	-$0.06	$0.25	$5.41 billion	$5.34 billion
5/5/2026	Q1 2026	TEM Tempus AI	-$0.21	-$0.13	+$0.08	-$0.71	$345.44 million	$348.12 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMED Amedisys	N/A	N/A	N/A	N/A	N/A
BTSG BrightSpring Health Services	N/A	N/A	N/A	N/A	N/A
FMS Fresenius Medical Care AG & Co. KGaA	$0.60	2.51%	+2.66%	31.58%	N/A
TEM Tempus AI	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMED Amedisys	0.26	1.36	1.36
BTSG BrightSpring Health Services	1.06	1.59	1.22
FMS Fresenius Medical Care AG & Co. KGaA	0.40	1.20	0.86
TEM Tempus AI	3.06	3.30	3.16

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMED Amedisys	94.36%
BTSG BrightSpring Health Services	N/A
FMS Fresenius Medical Care AG & Co. KGaA	8.37%
TEM Tempus AI	24.22%

Insider Ownership

Company	Insider Ownership
AMED Amedisys	2.10%
BTSG BrightSpring Health Services	2.80%
FMS Fresenius Medical Care AG & Co. KGaA	N/A
TEM Tempus AI	24.26%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMED Amedisys	20,000	32.89 million	32.20 million	Optionable
BTSG BrightSpring Health Services	23,500	197.86 million	191.76 million	Optionable
FMS Fresenius Medical Care AG & Co. KGaA	1,488	537.13 million	N/A	Optionable
TEM Tempus AI	3,800	179.57 million	136.00 million	N/A

AMED, FMS, BTSG, and TEM Headlines

Recent News About These Companies

Tempus AI (NASDAQ:TEM) Director David Epstein Sells 370 Shares of Stock

August 5 at 5:22 PM | marketbeat.com

Insider Selling: Tempus AI (NASDAQ:TEM) CEO Sells 23,818 Shares

August 5 at 5:06 PM | marketbeat.com

Medical Facilities (OTCMKTS:MFCSF) and Tempus AI (NASDAQ:TEM) Head to Head Review

August 5 at 4:49 AM | americanbankingnews.com

Stifel Nicolaus Issues Pessimistic Forecast for Tempus AI (NASDAQ:TEM) Stock Price

August 5 at 2:14 AM | americanbankingnews.com

BTIG Research Issues Pessimistic Forecast for Tempus AI (NASDAQ:TEM) Stock Price

August 5 at 1:24 AM | americanbankingnews.com

HC Wainwright Has Lowered Expectations for Tempus AI (NASDAQ:TEM) Stock Price

August 5 at 1:24 AM | americanbankingnews.com

Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic Applications

August 4 at 8:30 AM | businesswire.com

Tempus AI (NASDAQ:TEM) Price Target Cut to $70.00 by Analysts at BTIG Research

August 3 at 2:23 PM | marketbeat.com

Tempus AI (NASDAQ:TEM) Given New $56.00 Price Target at HC Wainwright

August 3 at 1:41 PM | marketbeat.com

Tempus AI (NASDAQ:TEM) Price Target Cut to $50.00 by Analysts at Stifel Nicolaus

August 3 at 8:23 AM | marketbeat.com

PERSONALIS SHAREHOLDER ALERT: PSNL Shareholders Interested in Pursuing Potential Claims Should Contact Julie & Holleman Regarding Proposed Sale to Tempus

August 3 at 7:45 AM | globenewswire.com

Tempus AI's (TEM) "Buy" Rating Reiterated at Needham & Company LLC

August 3 at 1:36 AM | americanbankingnews.com

Tempus AI (NASDAQ:TEM) CEO Sells $10,515,000.00 in Stock

August 2 at 4:09 AM | americanbankingnews.com

Tempus AI, Inc. Class A (TEM) Receives a Hold from Piper Sandler

August 1, 2026 | theglobeandmail.com

How Investors May Respond To Tempus AI (TEM) Q2 Profit Return, Outlook Hike, Personalis Deal

August 1, 2026 | uk.finance.yahoo.com

Avidity Partners Management LP Purchases New Stake in Tempus AI, Inc. $TEM

August 1, 2026 | marketbeat.com

Tempus AI–Personalis Deal: Integration Risks, Rising Costs, and Regulatory Scrutiny Could Undermine Synergy Gains

August 1, 2026 | tipranks.com

Insider Selling: Tempus AI (NASDAQ:TEM) CEO Sells 250,000 Shares of Stock

July 31, 2026 | marketbeat.com

Tempus AI Q2 Earnings Call Highlights

July 31, 2026 | marketbeat.com

Tempus AI, Inc. (TEM) Q2 2026 Earnings

July 31, 2026 | 247wallst.com

Tempus AI Inc (TEM) (Q2 2026) Earnings Call Highlights: Revenue Surges 22% to $382. ...

July 31, 2026 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

AMED, FMS, BTSG, and TEM Company Descriptions

Amedisys NASDAQ:AMED

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.

BrightSpring Health Services NASDAQ:BTSG

$63.02 +0.25 (+0.40%)

Closing price 04:00 PM Eastern

Extended Trading

$63.27 +0.25 (+0.40%)

As of 07:47 PM Eastern

BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.

Fresenius Medical Care AG & Co. KGaA NYSE:FMS

$23.91 -0.10 (-0.43%)

Closing price 03:59 PM Eastern

Extended Trading

$23.89 -0.02 (-0.07%)

As of 07:59 PM Eastern

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Tempus AI NASDAQ:TEM

$46.70 -0.35 (-0.74%)

Closing price 04:00 PM Eastern

Extended Trading

$46.55 -0.15 (-0.32%)

As of 07:59 PM Eastern

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AMED, FMS, BTSG, and TEM Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AMED, FMS, BTSG, and TEM Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AMED, FMS, BTSG, and TEM Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

AMED, FMS, BTSG, and TEM Company Descriptions

Amedisys NASDAQ:AMED

BrightSpring Health Services NASDAQ:BTSG

Fresenius Medical Care AG & Co. KGaA NYSE:FMS

Tempus AI NASDAQ:TEM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AMED, FMS, BTSG, and TEM Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AMED, FMS, BTSG, and TEM Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AMED, FMS, BTSG, and TEM Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

AMED, FMS, BTSG, and TEM Company Descriptions

Amedisys NASDAQ:AMED

BrightSpring Health Services NASDAQ:BTSG

Fresenius Medical Care AG & Co. KGaA NYSE:FMS

Tempus AI NASDAQ:TEM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools